As a Principal Automation Engineer at Vertex Pharmaceuticals, Howard Miller plays a pivotal role in advancing the company's drug discovery efforts through innovative automation solutions. With a robust background in High Throughput Screening (HTS) and Absorption, Distribution, Metabolism, and Elimination (ADME) screening, Howard leverages his...
As a Principal Automation Engineer at Vertex Pharmaceuticals, Howard Miller plays a pivotal role in advancing the company's drug discovery efforts through innovative automation solutions. With a robust background in High Throughput Screening (HTS) and Absorption, Distribution, Metabolism, and Elimination (ADME) screening, Howard leverages his extensive industrial experience to enhance the efficiency and accuracy of laboratory operations. His current responsibilities in the Human Assay Technologies Department involve the design and implementation of automated workflows that are critical for high-throughput screening, compound profiling, and genome editing.
Howard's expertise in protocol design, error recovery, and run execution is complemented by his proficiency in using advanced automation software such as HighRes Biosolutions Cellario, Thermo Scientific Momentum, and Hamilton Venus. His collaborative approach allows him to work closely with scientists to optimize existing processes and develop new methodologies that streamline data acquisition and analysis. By employing his skills in data mining and visualization, Howard ensures that the data generated from these automated systems is not only reliable but also actionable, facilitating informed decision-making in drug development.
Moreover, Howard's experience in assay development and cellular assays positions him as a key contributor to Vertex's mission of delivering transformative therapies. His adeptness in managing complex screening projects and his familiarity with life sciences further solidify his role as a leader in the field. As he continues to drive innovation in laboratory automation, Howard remains committed to enhancing the capabilities of Vertex Pharmaceuticals in the quest for groundbreaking treatments.
